Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Condensed Statements of Operations [Abstract]
Revenue
Operating expenses
General and administrative	1,115	126	2,504	188
Accretion Expense	(1,191)		47,172
Total operating expenses	(76)	126	49,676	188
Operating income (loss)	76	(126)	(49,676)	(188)
Non-operating (income) expense
Loss from Equity Method Investment in the Joint Venture	8,764	17,468	104,497	65,805
(Gain) Loss on Sale of Interests in the Joint Venture				(661)
Management fee income	(771)	(126)	(1,648)	(188)
Interest expense	602		1,246
Interest income	(601)		(1,245)
Amortization of debt discount and issuance costs	191		403
Unrealized (gain) loss on forward purchase contract	(74,084)		(71,649)
Total non-operating (income) expense	(65,899)	17,342	31,604	64,956
Income (loss) before income tax provision (benefit)	65,975	(17,468)	(81,280)	(65,144)
Income tax provision (benefit)	15,240	(5,080)	(564)	(16,664)
Net income (loss)	$ 50,735	$ (12,388)	$ (80,716)	$ (48,480)
Net income (loss) per share:
Basic	$ 0.35	$ (0.16)	$ (0.67)	$ (0.64)
Diluted	$ 0.35	$ (0.16)	$ (0.67)	$ (0.64)
Weighted average shares (see Note 5):
Basic	143,392,295	75,465,310	120,657,859	75,525,645
Diluted	146,201,860	75,465,310	120,657,859	75,525,645